Table 9.
Estimate of reduction in economic burden in Canada if all inhabitants had 25(OH)D concentrations >100 nmol/L after several years.
| Outcome | Total economic burden in 2016 ($B) | Reduction due to improving vitamin D status (%) | Reduction in economic burden due to improving vitamin D status ($B) | Deaths in Canada in 2011 39 | Reduction in deaths, using deaths for 2011 |
|---|---|---|---|---|---|
| Cancer | 7.3 | 15 | 1.1 | 72,476 | 10,870 |
| CVD | 24.6 | 14 | 3.4 | 60,910 | 8530 |
| Dementia | 16.2 | 7 | 1.1 | 10,000 | 700 |
| DM | 15.7 | 18 | 2.8 | 7194 | 1290 |
| MS | 3.7 | 40 | 1.5 | 500 Ref. 92 | 200 |
| Osteoporosis (hip fractures) | 5.0 | 22 | 1.1 | ||
| Respiratory infections | 6.1 | 25 | 1.5 | 5767 | 1440 |
| Total | 78.6 | 15.9 | 12.5 | 156,847 | 23,030 |
Note: Total deaths in Canada in 2011 were 242,07488
$B, billions of dollars; CVD, cardiovascular disease; DM, diabetes mellitus; MS, multiple sclerosis.